Intellipharmaceutics Corp. main strategy is one of creating value.  We achieve this by designing a business model that meets the needs of our corporate clients while increasing shareholder value.  With our strong enabling technologies and sound decision-making on partnering, Intellipharmaceutics Corp. intends to exceed customer expectations.

In essence, Intellipharmaceutics Corp. strategy involves “dual” approach:

	Intellipharmaceutics Corp. develops partnered products using our proprietary technology (ANDAs and NDAs)
	Intellipharmaceutics Corp. develops, files and markets our own products (ANDAs and NDAs)

Through this approach, Intellipharmaceutics Corp. ensures its short and long term success by leveraging our technology across both external and internal development opportunities.